Herantis Pharma Oyj : Managers’ Transactions – Tone Kvåle

Herantis Pharma Plc
Company release 18 Dec 2020 at 4:09 pm

Company release 18 Dec 2020 at 4:00pm EET

Herantis Pharma Oyj – Managers’ Transactions

____________________________________________

Person subject to the notification requirement

Name: Kvåle, Tone

Position: Chief Financial Officer

Issuer: Herantis Pharma Plc

LEI: 743700W4CQVYAT3WKK38

Notification type: INITIAL NOTIFICATION

Reference number: 743700W4CQVYAT3WKK38_20201218145324_2

____________________________________________

Transaction date: 2020-12-18

Venue: FIRST NORTH FINLAND (FNFI)

Instrument type: SHARE

ISIN: FI4000087861

Nature of the transaction: ACQUISITION

Transaction details

(1): Volume: 600 Unit price: 3.9 EUR

(2): Volume: 1,000 Unit price: 3.95 EUR

(3): Volume: 1,000 Unit price: 3.9 EUR

(4): Volume: 1,000 Unit price: 3.9 EUR

(5): Volume: 1,000 Unit price: 3.9 EUR

Aggregated transactions

(5): Volume: 4,600 Volume weighted average price: 3.91087 EUR

____________________________________________

Further information:

Julie Silber/Gabriela Urquilla

Tel: +46 (0)7 93 486 277/+46 (0)72-396 72 19

Email:ir@herantis.com

Certified Advisor: UB Securities Ltd, Finland: +358 9 25 380 225, Sweden: +358 40 5161400

Company website: www.herantis.com

Distribution:

Main media
www.herantis.com

Attachment